Theratechnologies Inc T.TH

Alternate Symbol(s): THTX

Healthcare Biotechnology

Theratechnologies Inc. is a Canada-based clinical-stage biopharmaceutical company. The Company is focused on the development and commercialization of therapies addressing unmet medical needs. It markets prescription products for people with human immunodeficiency viruses (HIV) in the United States. The Company's research pipeline focuses on specialized therapies addressing unmet medical needs in HIV, nonalcoholic steatohepatitis (NASH) and oncology. Its medicines include Trogarzo and EGRIFTA SV (tesamorelin for injection). Trogarzo (ibalizumab-uiyk) injection is a long-acting monoclonal antibody which binds to domain 2 of the CD4 T cell receptors. EGRIFTA SV (tesamorelin for injection) is approved in the United States for the reduction of excess abdominal fat in people with HIV who have lipodystrophy. Its portfolio includes Phase I clinical trial of sudocetaxel zendusortide (TH1902), a novel peptide-drug conjugate (PDC), in patients with advanced ovarian cancer.

TSX:TH - Post by User

Theratechnologies Inc > If ...or when....someday...

<< Previous

Bullboard Posts

Next >>

Post by FredTheVoiceon Apr 17, 2021 8:26am

189 Views

Post# 33016688

If ...or when....someday...

If this stock someday moves with half the energy shared on this board, well, some will be crying selling their shares at 20$......

Good work here,

And a great weekend to all, and your family members,

Yes it was a bad week, but sun will shine again,

FTV.

<< Previous

Bullboard Posts

Next >>

The top TSX healthcare stocks under $1